Confidential Financial Information. Archemix shall treat all financial information subject to review under this Section 5 as confidential, and shall cause its Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. accounting firm to retain all such financial information in confidence under Section 9 below.
Appears in 2 contracts
Samples: License Agreement (Nitromed Inc), License Agreement (Archemix Corp.)
Confidential Financial Information. Archemix shall treat all financial information subject to review under this Section 5 as confidential, and shall cause its Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. accounting firm to retain all such financial information in confidence under Section 9 10 below.
Appears in 2 contracts
Samples: Technology Development and License Agreement (Nitromed Inc), Technology Development and License Agreement (Archemix Corp.)
Confidential Financial Information. Archemix shall treat all financial information subject to review under this Section 5 as confidential, and shall cause its Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. accounting firm to retain all such financial information in confidence under Section 9 below.
Appears in 2 contracts
Samples: License Agreement (Regado Biosciences Inc), License Agreement (Regado Biosciences Inc)
